Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: A cost-effectiveness modelling study

The Lancet Global Health

Volumn 3, Issue 10, 2015, Pages e629-e638

  Lo, Nathan C ^a   Bogoch, Isaac I ^b,c   Blackburn, Brian G ^a   Raso, Giovanna ^d,e   N'Goran, Eliézer K ^f,g   Coulibaly, Jean T ^d,e,f,g   Becker, Sören L ^d,e,h   Abrams, Howard B ^b,c   Utzinger, Jürg ^d,e   Andrews, Jason R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^g CENTRE SUISSE DE RECHERCHES SCIENTIFIQUES EN CÔTE D'IVOIRE   (Côte d’Ivoire)

^h SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; PRAZIQUANTEL; ANTIPARASITIC AGENT; SOIL;

ANEMIA; ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG ADMINISTRATION; HELMINTHIASIS; HUMAN; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REINFECTION; SCHISTOSOMIASIS; SENSITIVITY ANALYSIS; ADOLESCENT; ADULT; CHILD; COMMUNITY CARE; COST BENEFIT ANALYSIS; COTE D'IVOIRE; ECONOMICS; FEMALE; HEALTH CARE COST; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PARASITOLOGY; PRESCHOOL CHILD; SOIL; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH SERVICES; COST-BENEFIT ANALYSIS; COTE D'IVOIRE; FEMALE; HEALTH CARE COSTS; HELMINTHIASIS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; SCHISTOSOMIASIS; SOIL; YOUNG ADULT;

EID: 84941767997     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(15)00047-9     Document Type: Article

References (59)

1. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors 2014, 7:37.
2. Colley DG, Bustinduy AL, Secor WE, King CH Human schistosomiasis. Lancet 2014, 383:2253-2264.
3. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation 2012, WHO, World Health Organization, Geneva.
4. Rollinson D, Knopp S, Levitz S, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop 2013, 128:423-440.
5. Truscott JE, Hollingsworth TD, Brooker SJ, Anderson RM Can chemotherapy alone eliminate the transmission of soil transmitted helminths?. Parasit Vectors 2014, 7:266.
6. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers 2006, WHO, World Health Organization, Geneva.
7. Guyatt H The cost of delivering and sustaining a control programme for schistosomiasis and soil-transmitted helminthiasis. Acta Trop 2003, 86:267-274.
8. King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl Trop Dis 2011, 5:e1321.
9. Hotez PJ, Kamath A Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 2009, 3:e412.
10. Karagiannis-Voules D-A, Biedermann P, Ekpo UF, et al. Spatial and temporal distribution of soil-transmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis. Lancet Infect Dis 2015, 15:74-84.
11. Helminth control in school-age children: a guide for managers of control programmes 2011, WHO, World Health Organization, Geneva. 2nd edn.
12. Anderson R, Truscott J, Hollingsworth TD The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos Trans R Soc Lond B Biol Sci 2014, 369:20130435.
13. Anderson RM, Truscott JE, Pullan RL, Brooker SJ, Hollingsworth TD How effective is school-based deworming for the community-wide control of soil-transmitted helminths?. PLoS Negl Trop Dis 2013, 7:e2027.
14. Chan MS, Guyatt HL, Bundy DAP, Medley GF The development and validation of an age-structured model for the evaluation of disease control strategies for intestinal helminths. Parasitology 1994, 109:389-396.
15. Anderson RM, May RM Infectious diseases of humans: dynamics and control 1991, Oxford University Press, Oxford.
16. Coulibaly JT, Fürst T, Silué KD, et al. Intestinal parasitic infections in schoolchildren in different settings of Côte d'Ivoire: effect of diagnostic approach and implications for control. Parasit Vectors 2012, 5:135.
17. Becker SL, Sieto B, Silué KD, et al. Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a co-endemic setting. PLoS Negl Trop Dis 2011, 5:e1292.
18. Raso G, Luginbühl A, Adjoua CA, et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol 2004, 33:1092-1102.
19. Keiser J, N'Goran EK, Traoré M, et al. Polyparasitism with Schistosoma mansoni, geohelminths, and intestinal protozoa in rural Côte d'Ivoire. J Parasitol 2002, 88:461-466.
20. Utzinger J, N'Goran EK, Esse Aya CM, et al. Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire. Trop Med Int Health 1998, 3:711-720.
21. King CH, Dickman K, Tisch DJ Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
22. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
23. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143.
24. World development indicators 2013, The World Bank, The World Bank, Washington, DC.
25. Tan-Torres Edejer T, Baltussen R, Adam T, et al. WHO guide to cost-effectiveness analysis 2003, World Health Organization, Geneva.
26. Anderson RM, May RM Population dynamics of human helminth infections: control by chemotherapy. Nature 1982, 297:557-563.
27. Danso-Appiah A, Olliaro PL, Donegan S, Sinclair D, Utzinger J Drugs for treating Schistosoma mansoni infection. Cochrane Database Syst Rev 2013, 2. CD000528.
28. Keiser J, Utzinger J Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008, 299:1937-1948.
29. Zwang J, Olliaro PL Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl Trop Dis 2014, 8:e3286.
30. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 2014, 123:615-624.
31. Smith JL, Brooker S Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop Med Int Health 2010, 15:776-795.
32. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity 2011, WHO, World Health Organization, Geneva.
33. Staubli-Asobayire F, Adou P, Davidsson L, Cook JD, Hurrell RF Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Côte d'Ivoire. Am J Clin Nutr 2001, 74:776-782.
34. Côte d'Ivoire: Neonatal and child health profile Department of Maternal, NewbornNewborn, Child and Adolescent HealthChild and Adolescent Health, WHO, (accessed Aug 25, 2015). http://www.who.int/maternal_child_adolescent/epidemiology/profiles/neonatal_child/civ.pdf.
35. Hall A, Hewitt G, Tuffrey V, de Silva N A review and meta-analysis of the impact of intestinal worms on child growth and nutrition. Matern Child Nutr 2008, 4(suppl 1):118-236.
36. Hürlimann E, Yapi RB, Houngbedji CA, et al. The epidemiology of polyparasitism and implications for morbidity in two rural communities of Côte d'Ivoire. Parasit Vectors 2014, 7:81.
37. van Baal PH, Hoeymans N, Hoogenveen RT, de Wit GA, Westert GP Disability weights for comorbidity and their influence on health-adjusted life expectancy. Popul Health Metr 2006, 4:1.
38. The world factbook US Central Intelligence Agency, (accessed April 15, 2015). https://www.cia.gov/library/publications/the-world-factbook/.
39. International drug price indicator guide, 2013 edition Management Sciences for Health, WHO, (accessed April 15, 2015). http://erc.msh.org/dmpguide/pdf/DrugPriceGuide_2013_en.pdf.
40. Goldman AS, Guisinger VH, Aikins M, et al. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl Trop Dis 2007, 1:e67.
41. Deworming for health and development: report of the third global meeting of the partners for parasite control 2005, WHO, World Health Organization, Geneva, (accessed April 15, 2015). http://whqlibdoc.who.int/hq/2005/WHO_CDS_CPE_PVC_2005.14.pdf.
42. Brooker S, Kabatereine NB, Fleming F, Devlin N Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up. Health Policy Plan 2008, 23:24-35.
43. Evans D, McFarland D, Adamani W, et al. Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria. Ann Trop Med Parasitol 2011, 105:537-547.
44. Fitzpatrick C, Asiedu K, Jannin J Where the road ends, yaws begins? The cost-effectiveness of eradication versus more roads. PLoS Negl Trop Dis 2014, 8:e3165.
45. Gabrielli AF, Touré S, Sellin B, et al. A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: performance, financial costs and implications for sustainability. Acta Trop 2006, 99:234-242.
46. Kabatereine NB, Tukahebwa EM, Kazibwe F, et al. Soil-transmitted helminthiasis in Uganda: epidemiology and cost of control. Trop Med Int Health 2005, 10:1187-1189.
47. Leslie J, Garba A, Boubacar K, et al. Neglected tropical diseases: comparison of the costs of integrated and vertical preventive chemotherapy treatment in Niger. Int Health 2013, 5:78-84.
48. Leslie J, Garba A, Oliva EB, et al. Schistosomiasis and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration [corrected]. PLoS Negl Trop Dis 2011, 5:e1326.
49. Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, Ross AG Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 2010, 10:733-736.
50. Schistosomiasis: number of people treated worldwide in 2013. Wkly Epidemiol Rec 2015, 90:25-32. WHO.
51. Sousa-Figueiredo JC, Betson M, Atuhaire A, et al. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children. PLoS Negl Trop Dis 2012, 6:e1864.
52. Health statistics and information systems. The global burden of disease: 2004 update 2004, WHO, World Health Organization, Geneva.
53. King CH, Dickman K, Tisch DJ Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
54. Aiken AM, Davey C, Hargreaves JR, Hayes RJ Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a pure replication. Int J Epidemiol 2015, published online July 22. 10.1093/ije/dyv127.
55. Davey C, Aiken AM, Hayes RJ, Hargreaves JR Re-analysis of health and educational impacts of a school-based deworming programme in western Kenya: a statistical replication of a cluster quasi-randomized stepped-wedge trial. Int J Epidemiol 2015, published online July 22. 10.1093/ije/dyv128.
56. Evans DS, King JD, Eigege A, et al. Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in central Nigeria. Am J Trop Med Hyg 2013, 88:441-445.
57. Njenga SM, Mwandawiro CS, Muniu E, Mwanje MT, Haji FM, Bockarie MJ Adult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policy. Parasit Vectors 2011, 4:175.
58. Bieri FA, Gray DJ, Williams GM, et al. Health-education package to prevent worm infections in Chinese schoolchildren. N Engl J Med 2013, 368:1603-1612.
59. Grimes JET, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR The relationship between water, sanitation and schistosomiasis: a systematic review and meta-analysis. PLoS Negl Trop Dis 2014, 8:e3296.